Thursday March 19th
19:45 live music by Bird of a Feather
The developments currently taking place in the production of sensors are mind boggling. Not only the detection limits have been improved greatly, but also many sensors can currently already be produced at large scale and at reasonable cost. This will influence and affect our daily lives, especially when these sensors are applied to personal health.
In this Science Café Prof. dr. Menno Prins and dr. Aart van Amerongen will address the state-of-the-art in sensing and diagnostics with respect to personalised drug dosing, so-called therapeutic drug monitoring (TDM). Aart van Amerongen will focus on the consequences of differences in the metabolism of drugs between people and on Point-of-Care diagnostics that can be used by patients at home and allow for wireless transfer of results to the doctor in attendance. Menno Prins will discuss innovative technologies for continuous monitoring, including applications in healthcare and industrial processing.
Aart van Amerongen is a senior scientist at Wageningen Food & Biobased Research and is heading the group BioSensing & Diagnostics. The group focuses on the development of rapid, multi-analyte diagnostic platforms and on applications in fields ranging from primary production to human health. He is one of the founders and organisers of the conference series Rapid Methods Europe of which the 13th event will be held in Amsterdam from 2-4 November 2020.
Menno Prins is professor at Eindhoven University of Technology. He investigates technologies for the continuous monitoring of biomolecules. He co-founded Helia Biomonitoring, a spin-off company for the development of continuous biosensing technologies. He founded and organizes SensUs, the annual international student competition on biosensors for health (www.sensus.org), with student teams participating from universities in Europe, North-America, Asia, and Africa.